Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | DiseaseId | DiseaseName | DiseaseMIM | ConceptID | Source | Typical association | HGMD variants | ClinVar variants | HGNC ID | GeneMIM |
---|
HPO disease - gene - phenotype typical associations: |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | ACTN4 CL E G H | 81 | 603278 | Focal segmental glomerulosclerosis 1 | 603278 | C0333497 | OMIM | 1 | | 308 | 166 | 604638 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | ANO3 CL E G H | 63982 | 615034 | Dystonia 24 | 615034 | C3554374 | OMIM | 1 | | 477 | 14004 | 610110 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | ANXA11 CL E G H | 311 | 617839 | AMYOTROPHIC LATERAL SCLEROSIS 23 | 617839 | CN778765 | OMIM | 1 | | 305 | 535 | 602572 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | ATL1 CL E G H | 51062 | 182600 | Spastic paraplegia 3 | 182600 | C2931355 | OMIM | 1 | | 517 | 11231 | 606439 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | ATP1A2 CL E G H | 477 | 602481 | Familial hemiplegic migraine type 2 | 602481 | C1865322 | OMIM | 1 | | 1117 | 800 | 182340 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | ATP1A3 CL E G H | 478 | 128235 | Dystonia 12 | 128235 | C1868681 | OMIM | 1 | | 993 | 801 | 182350 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | ATXN10 CL E G H | 25814 | 603516 | Spinocerebellar ataxia 10 | 603516 | C1963674 | OMIM | 1 | | 116 | 10549 | 611150 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | BMPR2 CL E G H | 659 | 178600 | Primary pulmonary hypertension | 178600 | C0152171 | OMIM | 1 | | 1028 | 1078 | 600799 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | CACNA1A CL E G H | 773 | 108500 | Episodic ataxia type 2 | 108500 | C1720416 | OMIM | 1 | | 3248 | 1388 | 601011 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | CACNA1S CL E G H | 779 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 1 | | 1886 | 1397 | 114208 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | CACNB4 CL E G H | 785 | 613855 | Episodic ataxia, type 5 | 613855 | C1866039 | OMIM | 1 | | 323 | 1404 | 601949 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | CAV1 CL E G H | 857 | 615343 | Primary pulmonary hypertension 3 | 615343 | C3809192 | OMIM | 1 | | 135 | 1527 | 601047 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | CFC1 CL E G H | 55997 | 605376 | Heterotaxy, visceral, 2, autosomal | 605376 | C1415817 | OMIM | 1 | | 46 | 18292 | 605194 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | CHRNA2 CL E G H | 1135 | 610353 | Epilepsy, nocturnal frontal lobe, type 4 | 610353 | C1835905 | OMIM | 1 | | 732 | 1956 | 118502 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | CHRNA4 CL E G H | 1137 | 600513 | Epilepsy, nocturnal frontal lobe, type 1 | 600513 | C1838049 | OMIM | 1 | | 1017 | 1958 | 118504 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | CLCN2 CL E G H | 1181 | 605635 | Hyperaldosteronism, familial, type II | 605635 | C1854107 | OMIM | 1 | | 403 | 2020 | 600570 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | COL4A2 CL E G H | 1284 | 614483 | Porencephaly 2 | 614483 | C3280970 | OMIM | 1 | | 1371 | 2203 | 120090 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | CPOX CL E G H | 1371 | 121300 | Hereditary coproporphyria | 121300 | C0162531 | OMIM | 1 | | 256 | 2321 | 612732 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | CRELD1 CL E G H | 78987 | 606217 | Atrioventricular septal defect 2 | 606217 | C1853508 | OMIM | 1 | | 193 | 14630 | 607170 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | CTLA4 CL E G H | 1493 | 616100 | Autoimmune lymphoproliferatiVe syndrome, type V | 616100 | C4015214 | OMIM | 1 | | 232 | 2505 | 123890 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | CTNNB1 CL E G H | 1499 | 155255 | Medulloblastoma | 155255 | C0025149 | OMIM | 1 | | 624 | 2514 | 116806 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | DCC CL E G H | 1630 | 157600 | Mirror movements 1 | 157600 | C1834870 | OMIM | 1 | | 259 | 2701 | 120470 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | DCX CL E G H | 1641 | 300067 | Lissencephaly, X-linked | 300067 | C1848199 | OMIM | 1 | | 423 | 2714 | 300121 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | DEPDC5 CL E G H | 9681 | 604364 | Epilepsy, familial focal, with variable foci 1 | 604364 | C1858477 | OMIM | 1 | | 1975 | 18423 | 614191 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | DSTYK CL E G H | 25778 | 610805 | Congenital anomalies of kidney and urinary tract 1, susceptibility to | 610805 | C1835826 | OMIM | 1 | | 171 | 29043 | 612666 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | ELOVL4 CL E G H | 6785 | 133190 | Erythrokeratodermia with ataxia | 133190 | C1851481 | OMIM | 1 | | 297 | 14415 | 605512 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | EYA1 CL E G H | 2138 | 602588 | Branchiootic syndrome | 602588 | C1865143 | OMIM | 1 | | 513 | 3519 | 601653 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | EYA1 CL E G H | 2138 | 113650 | Melnick-Fraser syndrome | 113650 | C0265234 | OMIM | 1 | | 513 | 3519 | 601653 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | FGF23 CL E G H | 8074 | 193100 | Autosomal dominant hypophosphatemic rickets | 193100 | C0342642 | OMIM | 1 | | 226 | 3680 | 605380 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | FGFR1 CL E G H | 2260 | 147950 | Kallmann syndrome 2 | 147950 | C1563720 | OMIM | 1 | | 936 | 3688 | 136350 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | FH CL E G H | 2271 | 150800 | Multiple cutaneous leiomyomas | 150800 | C1708350 | OMIM | 1 | | 1798 | 3700 | 136850 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | FLCN CL E G H | 201163 | 173600 | Pneumothorax, primary spontaneous | 173600 | C1868193 | OMIM | 1 | | 2185 | 27310 | 607273 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | FMR1 CL E G H | 2332 | 300624 | Fragile X syndrome | 300624 | C0016667 | OMIM | 1 | | 371 | 3775 | 309550 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | GATA5 CL E G H | 140628 | 617912 | CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5 | 617912 | CN873437 | OMIM | 1 | | 395 | 15802 | 611496 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | GJA5 CL E G H | 2702 | 612474 | 1q21.1 recurrent microdeletion | 612474 | C2675897 | OMIM | 1 | | 516 | 4279 | 121013 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | GJA8 CL E G H | 2703 | 612474 | 1q21.1 recurrent microdeletion | 612474 | C2675897 | OMIM | 1 | | 443 | 4281 | 600897 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | GJB1 CL E G H | 2705 | 302800 | X-linked hereditary motor and sensory neuropathy | 302800 | C0393808 | OMIM | 1 | | 860 | 4283 | 304040 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | GJC2 CL E G H | 57165 | 613480 | Lymphedema, hereditary, IC | 613480 | C3150732 | OMIM | 1 | | 323 | 17494 | 608803 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | GLI2 CL E G H | 2736 | 615849 | Culler-Jones syndrome | 615849 | C4014479 | OMIM | 1 | | 832 | 4318 | 165230 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | GLI2 CL E G H | 2736 | 610829 | Holoprosencephaly 9 | 610829 | C1835819 | OMIM | 1 | | 832 | 4318 | 165230 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | GREB1L CL E G H | 80000 | 617805 | RENAL HYPODYSPLASIA/APLASIA 3 | 617805 | C4540497 | OMIM | 1 | | 263 | 31042 | 617782 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | GRIN2A CL E G H | 2903 | 245570 | Epilepsy, focal, with speech disorder and with or without mental retardation | 245570 | C1832814 | OMIM | 1 | | 1836 | 4585 | 138253 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | HNRNPDL CL E G H | 9987 | 609115 | Limb-girdle muscular dystrophy, type 1G | 609115 | C1836765 | OMIM | 1 | | 354 | 5037 | 607137 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | IFIH1 CL E G H | 64135 | 615846 | Aicardi-Goutieres syndrome 7 | 615846 | C3888244 | OMIM | 1 | | 1170 | 18873 | 606951 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | IKZF1 CL E G H | 10320 | 616873 | Immunodeficiency, common variable, 13 | 616873 | C4225173 | OMIM | 1 | | 200 | 13176 | 603023 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | JAG1 CL E G H | 182 | 118450 | Alagille syndrome 1 | 118450 | C1956125 | OMIM | 1 | | 1605 | 6188 | 601920 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | KCNK3 CL E G H | 3777 | 615344 | Primary pulmonary hypertension 4 | 615344 | C3809198 | OMIM | 1 | | 185 | 6278 | 603220 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | KIF11 CL E G H | 3832 | 152950 | Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation | 152950 | C1835265 | OMIM | 1 | | 769 | 6388 | 148760 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | KMT2B CL E G H | 9757 | 617284 | Dystonia 28, childhood-onset | 617284 | C4310633 | OMIM | 1 | | 1303 | 15840 | 606834 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | KRIT1 CL E G H | 889 | 116860 | Cerebral cavernous malformation | 116860 | C2919945 | OMIM | 1 | | 578 | 1573 | 604214 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | LGI1 CL E G H | 9211 | 600512 | Epilepsy, lateral temporal lobe, autosomal dominant | 600512 | C1838062 | OMIM | 1 | | 443 | 6572 | 604619 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | LRP5 CL E G H | 4041 | 617875 | POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS | 617875 | CN818987 | OMIM | 1 | | 1819 | 6697 | 603506 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | LRSAM1 CL E G H | 90678 | 614436 | Charcot-Marie-Tooth disease type 2P | 614436 | C3280797 | OMIM | 1 | | 792 | 25135 | 610933 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MED13L CL E G H | 23389 | 608808 | Transposition of the great arteries, dextro-looped 1 | 608808 | C1837341 | OMIM | 1 | | 1047 | 22962 | 608771 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MET CL E G H | 4233 | 605074 | Renal cell carcinoma, papillary, 1 | 605074 | C0007134 | OMIM | 1 | | 3184 | 7029 | 164860 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MFN2 CL E G H | 9927 | 609260 | Charcot-Marie-Tooth disease, type 2A2A | 609260 | C1836485 | OMIM | 1 | | 1222 | 16877 | 608507 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MICAL1 CL E G H | 64780 | 600512 | Epilepsy, lateral temporal lobe, autosomal dominant | 600512 | C1838062 | OMIM | 1 | | 726 | 20619 | 607129 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MN1 CL E G H | 4330 | 607174 | Meningioma, familial | 607174 | C1333989 | OMIM | 1 | | 222 | 7180 | 156100 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MNX1 CL E G H | 3110 | 176450 | Currarino triad | 176450 | C1531773 | OMIM | 1 | | 327 | 4979 | 142994 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MSH6 CL E G H | 2956 | 614350 | Hereditary nonpolyposis colorectal cancer type 5 | 614350 | C1833477 | OMIM | 1 | | 8438 | 7329 | 600678 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MT-ATP6 CL E G H | 4508 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7414 | 516060 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MT-CO3 CL E G H | 4514 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7422 | 516050 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MT-CYB CL E G H | 4519 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7427 | 516020 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MT-ND1 CL E G H | 4535 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7455 | 516000 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MT-ND2 CL E G H | 4536 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7456 | 516001 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MT-ND4 CL E G H | 4538 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7459 | 516003 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MT-ND4L CL E G H | 4539 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7460 | 516004 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MT-ND5 CL E G H | 4540 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7461 | 516005 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | MT-ND6 CL E G H | 4541 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7462 | 516006 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | NEXMIF CL E G H | 340533 | 300912 | Mental retardation, X-linked 98 | 300912 | C3806730 | OMIM | 1 | | 990 | 29433 | 300524 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | NF2 CL E G H | 4771 | 607174 | Meningioma, familial | 607174 | C1333989 | OMIM | 1 | | 1783 | 7773 | 607379 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | NF2 CL E G H | 4771 | 162091 | Schwannomatosis 1 | 162091 | C4048809 | OMIM | 1 | | 1783 | 7773 | 607379 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | NLRP12 CL E G H | 91662 | 611762 | Familial cold autoinflammatory syndrome 2 | 611762 | C2673198 | OMIM | 1 | | 1036 | 22938 | 609648 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | NME1 CL E G H | 4830 | 256700 | Neuroblastoma | 256700 | C0027819 | OMIM | 1 | | 16 | 7849 | 156490 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | NPRL2 CL E G H | 10641 | 617116 | Epilepsy, familial focal, with variable foci 2 | 617116 | C4310709 | OMIM | 1 | | 87 | 24969 | 607072 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | NPRL3 CL E G H | 8131 | 617118 | Epilepsy, familial focal, with variable foci 3 | 617118 | C4310708 | OMIM | 1 | | 898 | 14124 | 600928 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | NR5A1 CL E G H | 2516 | 617480 | 46,XX sex reversal 4 | 617480 | C4479552 | OMIM | 1 | | 251 | 7983 | 184757 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | NRIP1 CL E G H | 8204 | 618270 | 618270 | 618270 | | OMIM | 1 | | 212 | 8001 | 602490 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | OPA1 CL E G H | 4976 | 165500 | Dominant hereditary optic atrophy | 165500 | C0338508 | OMIM | 1 | | 1224 | 8140 | 605290 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PARN CL E G H | 5073 | 616371 | Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4 | 616371 | C4225347 | OMIM | 1 | | 627 | 8609 | 604212 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PAX2 CL E G H | 5076 | 616002 | Focal segmental glomerulosclerosis 7 | 616002 | C4014925 | OMIM | 1 | | 406 | 8616 | 167409 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PDGFB CL E G H | 5155 | 607174 | Meningioma, familial | 607174 | C1333989 | OMIM | 1 | | 151 | 8800 | 190040 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PITX1 CL E G H | 5307 | 119800 | Talipes equinovarus | 119800 | C0009081 | OMIM | 1 | | 85 | 9004 | 602149 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PKD2 CL E G H | 5311 | 613095 | Polycystic kidney disease 2 | 613095 | C2751306 | OMIM | 1 | | 840 | 9009 | 173910 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PRCC CL E G H | 5546 | 605074 | Renal cell carcinoma, papillary, 1 | 605074 | C0007134 | OMIM | 1 | | 28 | 9343 | 179755 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PRKCG CL E G H | 5582 | 605361 | Spinocerebellar ataxia 14 | 605361 | C1854369 | OMIM | 1 | | 323 | 9402 | 176980 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PROK2 CL E G H | 60675 | 610628 | Hypogonadotropic hypogonadism 4 with or without anosmia | 610628 | C1857720 | OMIM | 1 | | 65 | 18455 | 607002 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PROKR2 CL E G H | 128674 | 244200 | Kallmann syndrome 3 | 244200 | C2930927 | OMIM | 1 | | 160 | 15836 | 607123 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PRPF31 CL E G H | 26121 | 600138 | Retinitis pigmentosa 11 | 600138 | C1838601 | OMIM | 1 | | 629 | 15446 | 606419 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PRPF8 CL E G H | 10594 | 600059 | Retinitis pigmentosa 13 | 600059 | C1838702 | OMIM | 1 | | 1240 | 17340 | 607300 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PRRT2 CL E G H | 112476 | 128200 | Dystonia 10 | 128200 | C1868682 | OMIM | 1 | | 799 | 30500 | 614386 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PRRT2 CL E G H | 112476 | 605751 | Seizures, benign familial infantile, 2 | 605751 | C1853995 | OMIM | 1 | | 799 | 30500 | 614386 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PTCH1 CL E G H | 5727 | 610828 | Holoprosencephaly 7 | 610828 | C1835820 | OMIM | 1 | | 4487 | 9585 | 601309 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PTCH2 CL E G H | 8643 | 155255 | Medulloblastoma | 155255 | C0025149 | OMIM | 1 | | 791 | 9586 | 603673 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | PUM1 CL E G H | 9698 | 617931 | SPINOCEREBELLAR ATAXIA 47 | 617931 | CN244564 | OMIM | 1 | | 175 | 14957 | 607204 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | RELN CL E G H | 5649 | 600512 | Epilepsy, lateral temporal lobe, autosomal dominant | 600512 | C1838062 | OMIM | 1 | | 2972 | 9957 | 600514 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | RPS29 CL E G H | 6235 | 615909 | Diamond-Blackfan anemia 13 | 615909 | C4014641 | OMIM | 1 | | 50 | 10419 | 603633 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | RTEL1 CL E G H | 51750 | 616373 | Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3 | 616373 | C4225346 | OMIM | 1 | | 2597 | 15888 | 608833 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | SCN1B CL E G H | 6324 | 604233 | Generalized epilepsy with febrile seizures plus, type 1 | 604233 | C1858672 | OMIM | 1 | | 511 | 10586 | 600235 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | SCN4A CL E G H | 6329 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 1 | | 1765 | 10591 | 603967 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | SDHB CL E G H | 6390 | 115310 | Paragangliomas 4 | 115310 | C1861848 | OMIM | 1 | | 1249 | 10681 | 185470 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | SFTPC CL E G H | 6440 | 610913 | Surfactant metabolism dysfunction, pulmonary, 2 | 610913 | C1970470 | OMIM | 1 | | 215 | 10802 | 178620 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | SGCE CL E G H | 8910 | 159900 | Myoclonic dystonia | 159900 | C1834570 | OMIM | 1 | | 568 | 10808 | 604149 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | SHH CL E G H | 6469 | 142945 | Holoprosencephaly 3 | 142945 | C1840529 | OMIM | 1 | | 429 | 10848 | 600725 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | SHH CL E G H | 6469 | 611638 | Microphthalmia, isolated, with coloboma 5 | 611638 | C1968843 | OMIM | 1 | | 429 | 10848 | 600725 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | SIX1 CL E G H | 6495 | 113650 | Melnick-Fraser syndrome | 113650 | C0265234 | OMIM | 1 | | 195 | 10887 | 601205 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | SIX3 CL E G H | 6496 | 157170 | Holoprosencephaly 2 | 157170 | C1834877 | OMIM | 1 | | 183 | 10889 | 603714 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | SLC2A1 CL E G H | 6513 | 612126 | GLUT1 deficiency syndrome 2 | 612126 | C1842534 | OMIM | 1 | | 965 | 11005 | 138140 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | SMAD9 CL E G H | 4093 | 615342 | Primary pulmonary hypertension 2 | 615342 | C3888002 | OMIM | 1 | | 176 | 6774 | 603295 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | STAT1 CL E G H | 6772 | 614892 | Immunodeficiency 31a | 614892 | C4013950 | OMIM | 1 | | 557 | 11362 | 600555 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | SUFU CL E G H | 51684 | 155255 | Medulloblastoma | 155255 | C0025149 | OMIM | 1 | | 1306 | 16466 | 607035 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | TRPV4 CL E G H | 59341 | 606071 | Charcot-Marie-Tooth disease type 2C | 606071 | C2079540 | OMIM | 1 | | 1018 | 18083 | 605427 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | TRPV4 CL E G H | 59341 | 600175 | Distal spinal muscular atrophy, congenital nonprogressive | 600175 | C1838492 | OMIM | 1 | | 1018 | 18083 | 605427 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | TRPV4 CL E G H | 59341 | 181405 | Scapuloperoneal spinal muscular atrophy | 181405 | C0751335 | OMIM | 1 | | 1018 | 18083 | 605427 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | TTN CL E G H | 7273 | 600334 | Distal myopathy Markesbery-Griggs type | 600334 | C1838244 | OMIM | 1 | | 27503 | 12403 | 188840 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | VMA21 CL E G H | 203547 | 310440 | Myopathy, X-linked, with excessive autophagy | 310440 | C1839615 | OMIM | 1 | | 254 | 22082 | 300913 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | VWF CL E G H | 7450 | 193400 | von Willebrand disease type 1 | 193400 | C1264039 | OMIM | 1 | | 1385 | 12726 | 613160 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | WNT10B CL E G H | 7480 | 225300 | Split-hand/foot malformation 6 | 225300 | C2749665 | OMIM | 1 | | 85 | 12775 | 601906 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | ACTN4 CL E G H | 81 | 603278 | Focal segmental glomerulosclerosis 1 | 603278 | C0333497 | OMIM | 1 | | 308 | 166 | 604638 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | ANO3 CL E G H | 63982 | 615034 | Dystonia 24 | 615034 | C3554374 | OMIM | 1 | | 477 | 14004 | 610110 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | ANXA11 CL E G H | 311 | 617839 | AMYOTROPHIC LATERAL SCLEROSIS 23 | 617839 | CN778765 | OMIM | 1 | | 305 | 535 | 602572 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | ATL1 CL E G H | 51062 | 182600 | Spastic paraplegia 3 | 182600 | C2931355 | OMIM | 1 | | 517 | 11231 | 606439 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | ATP1A2 CL E G H | 477 | 602481 | Familial hemiplegic migraine type 2 | 602481 | C1865322 | OMIM | 1 | | 1117 | 800 | 182340 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | ATP1A3 CL E G H | 478 | 128235 | Dystonia 12 | 128235 | C1868681 | OMIM | 1 | | 993 | 801 | 182350 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | ATXN10 CL E G H | 25814 | 603516 | Spinocerebellar ataxia 10 | 603516 | C1963674 | OMIM | 1 | | 116 | 10549 | 611150 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | BMPR2 CL E G H | 659 | 178600 | Primary pulmonary hypertension | 178600 | C0152171 | OMIM | 1 | | 1028 | 1078 | 600799 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | CACNA1A CL E G H | 773 | 108500 | Episodic ataxia type 2 | 108500 | C1720416 | OMIM | 1 | | 3248 | 1388 | 601011 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | CACNA1S CL E G H | 779 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 1 | | 1886 | 1397 | 114208 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | CACNB4 CL E G H | 785 | 613855 | Episodic ataxia, type 5 | 613855 | C1866039 | OMIM | 1 | | 323 | 1404 | 601949 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | CAV1 CL E G H | 857 | 615343 | Primary pulmonary hypertension 3 | 615343 | C3809192 | OMIM | 1 | | 135 | 1527 | 601047 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | CFC1 CL E G H | 55997 | 605376 | Heterotaxy, visceral, 2, autosomal | 605376 | C1415817 | OMIM | 1 | | 46 | 18292 | 605194 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | CHRNA2 CL E G H | 1135 | 610353 | Epilepsy, nocturnal frontal lobe, type 4 | 610353 | C1835905 | OMIM | 1 | | 732 | 1956 | 118502 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | CHRNA4 CL E G H | 1137 | 600513 | Epilepsy, nocturnal frontal lobe, type 1 | 600513 | C1838049 | OMIM | 1 | | 1017 | 1958 | 118504 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | CLCN2 CL E G H | 1181 | 605635 | Hyperaldosteronism, familial, type II | 605635 | C1854107 | OMIM | 1 | | 403 | 2020 | 600570 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | COL4A2 CL E G H | 1284 | 614483 | Porencephaly 2 | 614483 | C3280970 | OMIM | 1 | | 1371 | 2203 | 120090 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | CPOX CL E G H | 1371 | 121300 | Hereditary coproporphyria | 121300 | C0162531 | OMIM | 1 | | 256 | 2321 | 612732 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | CRELD1 CL E G H | 78987 | 606217 | Atrioventricular septal defect 2 | 606217 | C1853508 | OMIM | 1 | | 193 | 14630 | 607170 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | CTLA4 CL E G H | 1493 | 616100 | Autoimmune lymphoproliferatiVe syndrome, type V | 616100 | C4015214 | OMIM | 1 | | 232 | 2505 | 123890 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | CTNNB1 CL E G H | 1499 | 155255 | Medulloblastoma | 155255 | C0025149 | OMIM | 1 | | 624 | 2514 | 116806 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | DCC CL E G H | 1630 | 157600 | Mirror movements 1 | 157600 | C1834870 | OMIM | 1 | | 259 | 2701 | 120470 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | DCX CL E G H | 1641 | 300067 | Lissencephaly, X-linked | 300067 | C1848199 | OMIM | 1 | | 423 | 2714 | 300121 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | DEPDC5 CL E G H | 9681 | 604364 | Epilepsy, familial focal, with variable foci 1 | 604364 | C1858477 | OMIM | 1 | | 1975 | 18423 | 614191 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | DSTYK CL E G H | 25778 | 610805 | Congenital anomalies of kidney and urinary tract 1, susceptibility to | 610805 | C1835826 | OMIM | 1 | | 171 | 29043 | 612666 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | ELOVL4 CL E G H | 6785 | 133190 | Erythrokeratodermia with ataxia | 133190 | C1851481 | OMIM | 1 | | 297 | 14415 | 605512 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | EYA1 CL E G H | 2138 | 602588 | Branchiootic syndrome | 602588 | C1865143 | OMIM | 1 | | 513 | 3519 | 601653 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | EYA1 CL E G H | 2138 | 113650 | Melnick-Fraser syndrome | 113650 | C0265234 | OMIM | 1 | | 513 | 3519 | 601653 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | FGF23 CL E G H | 8074 | 193100 | Autosomal dominant hypophosphatemic rickets | 193100 | C0342642 | OMIM | 1 | | 226 | 3680 | 605380 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | FGFR1 CL E G H | 2260 | 147950 | Kallmann syndrome 2 | 147950 | C1563720 | OMIM | 1 | | 936 | 3688 | 136350 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | FH CL E G H | 2271 | 150800 | Multiple cutaneous leiomyomas | 150800 | C1708350 | OMIM | 1 | | 1798 | 3700 | 136850 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | FLCN CL E G H | 201163 | 173600 | Pneumothorax, primary spontaneous | 173600 | C1868193 | OMIM | 1 | | 2185 | 27310 | 607273 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | FMR1 CL E G H | 2332 | 300624 | Fragile X syndrome | 300624 | C0016667 | OMIM | 1 | | 371 | 3775 | 309550 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | GATA5 CL E G H | 140628 | 617912 | CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5 | 617912 | CN873437 | OMIM | 1 | | 395 | 15802 | 611496 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | GJA5 CL E G H | 2702 | 612474 | 1q21.1 recurrent microdeletion | 612474 | C2675897 | OMIM | 1 | | 516 | 4279 | 121013 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | GJA8 CL E G H | 2703 | 612474 | 1q21.1 recurrent microdeletion | 612474 | C2675897 | OMIM | 1 | | 443 | 4281 | 600897 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | GJB1 CL E G H | 2705 | 302800 | X-linked hereditary motor and sensory neuropathy | 302800 | C0393808 | OMIM | 1 | | 860 | 4283 | 304040 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | GJC2 CL E G H | 57165 | 613480 | Lymphedema, hereditary, IC | 613480 | C3150732 | OMIM | 1 | | 323 | 17494 | 608803 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | GLI2 CL E G H | 2736 | 615849 | Culler-Jones syndrome | 615849 | C4014479 | OMIM | 1 | | 832 | 4318 | 165230 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | GLI2 CL E G H | 2736 | 610829 | Holoprosencephaly 9 | 610829 | C1835819 | OMIM | 1 | | 832 | 4318 | 165230 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | GREB1L CL E G H | 80000 | 617805 | RENAL HYPODYSPLASIA/APLASIA 3 | 617805 | C4540497 | OMIM | 1 | | 263 | 31042 | 617782 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | GRIN2A CL E G H | 2903 | 245570 | Epilepsy, focal, with speech disorder and with or without mental retardation | 245570 | C1832814 | OMIM | 1 | | 1836 | 4585 | 138253 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | HNRNPDL CL E G H | 9987 | 609115 | Limb-girdle muscular dystrophy, type 1G | 609115 | C1836765 | OMIM | 1 | | 354 | 5037 | 607137 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | IFIH1 CL E G H | 64135 | 615846 | Aicardi-Goutieres syndrome 7 | 615846 | C3888244 | OMIM | 1 | | 1170 | 18873 | 606951 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | IKZF1 CL E G H | 10320 | 616873 | Immunodeficiency, common variable, 13 | 616873 | C4225173 | OMIM | 1 | | 200 | 13176 | 603023 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | JAG1 CL E G H | 182 | 118450 | Alagille syndrome 1 | 118450 | C1956125 | OMIM | 1 | | 1605 | 6188 | 601920 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | KCNK3 CL E G H | 3777 | 615344 | Primary pulmonary hypertension 4 | 615344 | C3809198 | OMIM | 1 | | 185 | 6278 | 603220 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | KIF11 CL E G H | 3832 | 152950 | Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation | 152950 | C1835265 | OMIM | 1 | | 769 | 6388 | 148760 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | KMT2B CL E G H | 9757 | 617284 | Dystonia 28, childhood-onset | 617284 | C4310633 | OMIM | 1 | | 1303 | 15840 | 606834 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | KRIT1 CL E G H | 889 | 116860 | Cerebral cavernous malformation | 116860 | C2919945 | OMIM | 1 | | 578 | 1573 | 604214 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | LGI1 CL E G H | 9211 | 600512 | Epilepsy, lateral temporal lobe, autosomal dominant | 600512 | C1838062 | OMIM | 1 | | 443 | 6572 | 604619 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | LRP5 CL E G H | 4041 | 617875 | POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS | 617875 | CN818987 | OMIM | 1 | | 1819 | 6697 | 603506 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | LRSAM1 CL E G H | 90678 | 614436 | Charcot-Marie-Tooth disease type 2P | 614436 | C3280797 | OMIM | 1 | | 792 | 25135 | 610933 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MED13L CL E G H | 23389 | 608808 | Transposition of the great arteries, dextro-looped 1 | 608808 | C1837341 | OMIM | 1 | | 1047 | 22962 | 608771 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MET CL E G H | 4233 | 605074 | Renal cell carcinoma, papillary, 1 | 605074 | C0007134 | OMIM | 1 | | 3184 | 7029 | 164860 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MFN2 CL E G H | 9927 | 609260 | Charcot-Marie-Tooth disease, type 2A2A | 609260 | C1836485 | OMIM | 1 | | 1222 | 16877 | 608507 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MICAL1 CL E G H | 64780 | 600512 | Epilepsy, lateral temporal lobe, autosomal dominant | 600512 | C1838062 | OMIM | 1 | | 726 | 20619 | 607129 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MN1 CL E G H | 4330 | 607174 | Meningioma, familial | 607174 | C1333989 | OMIM | 1 | | 222 | 7180 | 156100 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MNX1 CL E G H | 3110 | 176450 | Currarino triad | 176450 | C1531773 | OMIM | 1 | | 327 | 4979 | 142994 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MSH6 CL E G H | 2956 | 614350 | Hereditary nonpolyposis colorectal cancer type 5 | 614350 | C1833477 | OMIM | 1 | | 8438 | 7329 | 600678 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MT-ATP6 CL E G H | 4508 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7414 | 516060 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MT-CO3 CL E G H | 4514 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7422 | 516050 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MT-CYB CL E G H | 4519 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7427 | 516020 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MT-ND1 CL E G H | 4535 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7455 | 516000 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MT-ND2 CL E G H | 4536 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7456 | 516001 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MT-ND4 CL E G H | 4538 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7459 | 516003 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MT-ND4L CL E G H | 4539 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7460 | 516004 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MT-ND5 CL E G H | 4540 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7461 | 516005 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | MT-ND6 CL E G H | 4541 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7462 | 516006 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | NEXMIF CL E G H | 340533 | 300912 | Mental retardation, X-linked 98 | 300912 | C3806730 | OMIM | 1 | | 990 | 29433 | 300524 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | NF2 CL E G H | 4771 | 607174 | Meningioma, familial | 607174 | C1333989 | OMIM | 1 | | 1783 | 7773 | 607379 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | NF2 CL E G H | 4771 | 162091 | Schwannomatosis 1 | 162091 | C4048809 | OMIM | 1 | | 1783 | 7773 | 607379 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | NLRP12 CL E G H | 91662 | 611762 | Familial cold autoinflammatory syndrome 2 | 611762 | C2673198 | OMIM | 1 | | 1036 | 22938 | 609648 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | NME1 CL E G H | 4830 | 256700 | Neuroblastoma | 256700 | C0027819 | OMIM | 1 | | 16 | 7849 | 156490 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | NPRL2 CL E G H | 10641 | 617116 | Epilepsy, familial focal, with variable foci 2 | 617116 | C4310709 | OMIM | 1 | | 87 | 24969 | 607072 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | NPRL3 CL E G H | 8131 | 617118 | Epilepsy, familial focal, with variable foci 3 | 617118 | C4310708 | OMIM | 1 | | 898 | 14124 | 600928 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | NR5A1 CL E G H | 2516 | 617480 | 46,XX sex reversal 4 | 617480 | C4479552 | OMIM | 1 | | 251 | 7983 | 184757 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | NRIP1 CL E G H | 8204 | 618270 | 618270 | 618270 | | OMIM | 1 | | 212 | 8001 | 602490 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | OPA1 CL E G H | 4976 | 165500 | Dominant hereditary optic atrophy | 165500 | C0338508 | OMIM | 1 | | 1224 | 8140 | 605290 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PARN CL E G H | 5073 | 616371 | Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4 | 616371 | C4225347 | OMIM | 1 | | 627 | 8609 | 604212 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PAX2 CL E G H | 5076 | 616002 | Focal segmental glomerulosclerosis 7 | 616002 | C4014925 | OMIM | 1 | | 406 | 8616 | 167409 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PDGFB CL E G H | 5155 | 607174 | Meningioma, familial | 607174 | C1333989 | OMIM | 1 | | 151 | 8800 | 190040 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PITX1 CL E G H | 5307 | 119800 | Talipes equinovarus | 119800 | C0009081 | OMIM | 1 | | 85 | 9004 | 602149 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PKD2 CL E G H | 5311 | 613095 | Polycystic kidney disease 2 | 613095 | C2751306 | OMIM | 1 | | 840 | 9009 | 173910 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PRCC CL E G H | 5546 | 605074 | Renal cell carcinoma, papillary, 1 | 605074 | C0007134 | OMIM | 1 | | 28 | 9343 | 179755 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PRKCG CL E G H | 5582 | 605361 | Spinocerebellar ataxia 14 | 605361 | C1854369 | OMIM | 1 | | 323 | 9402 | 176980 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PROK2 CL E G H | 60675 | 610628 | Hypogonadotropic hypogonadism 4 with or without anosmia | 610628 | C1857720 | OMIM | 1 | | 65 | 18455 | 607002 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PROKR2 CL E G H | 128674 | 244200 | Kallmann syndrome 3 | 244200 | C2930927 | OMIM | 1 | | 160 | 15836 | 607123 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PRPF31 CL E G H | 26121 | 600138 | Retinitis pigmentosa 11 | 600138 | C1838601 | OMIM | 1 | | 629 | 15446 | 606419 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PRPF8 CL E G H | 10594 | 600059 | Retinitis pigmentosa 13 | 600059 | C1838702 | OMIM | 1 | | 1240 | 17340 | 607300 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PRRT2 CL E G H | 112476 | 128200 | Dystonia 10 | 128200 | C1868682 | OMIM | 1 | | 799 | 30500 | 614386 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PRRT2 CL E G H | 112476 | 605751 | Seizures, benign familial infantile, 2 | 605751 | C1853995 | OMIM | 1 | | 799 | 30500 | 614386 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PTCH1 CL E G H | 5727 | 610828 | Holoprosencephaly 7 | 610828 | C1835820 | OMIM | 1 | | 4487 | 9585 | 601309 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PTCH2 CL E G H | 8643 | 155255 | Medulloblastoma | 155255 | C0025149 | OMIM | 1 | | 791 | 9586 | 603673 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | PUM1 CL E G H | 9698 | 617931 | SPINOCEREBELLAR ATAXIA 47 | 617931 | CN244564 | OMIM | 1 | | 175 | 14957 | 607204 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | RELN CL E G H | 5649 | 600512 | Epilepsy, lateral temporal lobe, autosomal dominant | 600512 | C1838062 | OMIM | 1 | | 2972 | 9957 | 600514 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | RPS29 CL E G H | 6235 | 615909 | Diamond-Blackfan anemia 13 | 615909 | C4014641 | OMIM | 1 | | 50 | 10419 | 603633 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | RTEL1 CL E G H | 51750 | 616373 | Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3 | 616373 | C4225346 | OMIM | 1 | | 2597 | 15888 | 608833 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | SCN1B CL E G H | 6324 | 604233 | Generalized epilepsy with febrile seizures plus, type 1 | 604233 | C1858672 | OMIM | 1 | | 511 | 10586 | 600235 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | SCN4A CL E G H | 6329 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 1 | | 1765 | 10591 | 603967 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | SDHB CL E G H | 6390 | 115310 | Paragangliomas 4 | 115310 | C1861848 | OMIM | 1 | | 1249 | 10681 | 185470 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | SFTPC CL E G H | 6440 | 610913 | Surfactant metabolism dysfunction, pulmonary, 2 | 610913 | C1970470 | OMIM | 1 | | 215 | 10802 | 178620 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | SGCE CL E G H | 8910 | 159900 | Myoclonic dystonia | 159900 | C1834570 | OMIM | 1 | | 568 | 10808 | 604149 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | SHH CL E G H | 6469 | 142945 | Holoprosencephaly 3 | 142945 | C1840529 | OMIM | 1 | | 429 | 10848 | 600725 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | SHH CL E G H | 6469 | 611638 | Microphthalmia, isolated, with coloboma 5 | 611638 | C1968843 | OMIM | 1 | | 429 | 10848 | 600725 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | SIX1 CL E G H | 6495 | 113650 | Melnick-Fraser syndrome | 113650 | C0265234 | OMIM | 1 | | 195 | 10887 | 601205 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | SIX3 CL E G H | 6496 | 157170 | Holoprosencephaly 2 | 157170 | C1834877 | OMIM | 1 | | 183 | 10889 | 603714 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | SLC2A1 CL E G H | 6513 | 612126 | GLUT1 deficiency syndrome 2 | 612126 | C1842534 | OMIM | 1 | | 965 | 11005 | 138140 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | SMAD9 CL E G H | 4093 | 615342 | Primary pulmonary hypertension 2 | 615342 | C3888002 | OMIM | 1 | | 176 | 6774 | 603295 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | STAT1 CL E G H | 6772 | 614892 | Immunodeficiency 31a | 614892 | C4013950 | OMIM | 1 | | 557 | 11362 | 600555 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | SUFU CL E G H | 51684 | 155255 | Medulloblastoma | 155255 | C0025149 | OMIM | 1 | | 1306 | 16466 | 607035 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | TRPV4 CL E G H | 59341 | 606071 | Charcot-Marie-Tooth disease type 2C | 606071 | C2079540 | OMIM | 1 | | 1018 | 18083 | 605427 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | TRPV4 CL E G H | 59341 | 600175 | Distal spinal muscular atrophy, congenital nonprogressive | 600175 | C1838492 | OMIM | 1 | | 1018 | 18083 | 605427 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | TRPV4 CL E G H | 59341 | 181405 | Scapuloperoneal spinal muscular atrophy | 181405 | C0751335 | OMIM | 1 | | 1018 | 18083 | 605427 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | TTN CL E G H | 7273 | 600334 | Distal myopathy Markesbery-Griggs type | 600334 | C1838244 | OMIM | 1 | | 27503 | 12403 | 188840 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | VMA21 CL E G H | 203547 | 310440 | Myopathy, X-linked, with excessive autophagy | 310440 | C1839615 | OMIM | 1 | | 254 | 22082 | 300913 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | VWF CL E G H | 7450 | 193400 | von Willebrand disease type 1 | 193400 | C1264039 | OMIM | 1 | | 1385 | 12726 | 613160 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | WNT10B CL E G H | 7480 | 225300 | Split-hand/foot malformation 6 | 225300 | C2749665 | OMIM | 1 | | 85 | 12775 | 601906 |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | CHRNA7 CL E G H | 1139 | 612001 | 15q13.3 microdeletion syndrome | 612001 | C2677613 | OMIM | 0 | | 384 | 1960 | 118511 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | KLF13 CL E G H | 51621 | 612001 | 15q13.3 microdeletion syndrome | 612001 | C2677613 | OMIM | 0 | | 253 | 13672 | 605328 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | RAD51 CL E G H | 5888 | 614508 | Mirror movements 2 | 614508 | C3281089 | OMIM | 0 | | 358 | 9817 | 179617 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | THAP1 CL E G H | 55145 | 602629 | Dystonia 6, torsion | 602629 | C1414216 | OMIM | 0 | | 206 | 20856 | 609520 |
HP:0003829 | HP:0003829 | Incomplete penetrance | 0 | TOR1A CL E G H | 1861 | 128100 | Dystonia 1 | 128100 | C1851945 | OMIM | 0 | | 220 | 3098 | 605204 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | CHRNA7 CL E G H | 1139 | 612001 | 15q13.3 microdeletion syndrome | 612001 | C2677613 | OMIM | 0 | | 384 | 1960 | 118511 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | KLF13 CL E G H | 51621 | 612001 | 15q13.3 microdeletion syndrome | 612001 | C2677613 | OMIM | 0 | | 253 | 13672 | 605328 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | RAD51 CL E G H | 5888 | 614508 | Mirror movements 2 | 614508 | C3281089 | OMIM | 0 | | 358 | 9817 | 179617 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | THAP1 CL E G H | 55145 | 602629 | Dystonia 6, torsion | 602629 | C1414216 | OMIM | 0 | | 206 | 20856 | 609520 |
HP:0003829 | HP:0003831 | Age-dependent penetrance | 1 | TOR1A CL E G H | 1861 | 128100 | Dystonia 1 | 128100 | C1851945 | OMIM | 0 | | 220 | 3098 | 605204 |